Page 26 - TD-1-1
P. 26

Tumor Discovery                                                         Monocytes from single-cell analysis



               tumour immunity and immunotherapy. Nat Rev Immunol,   106. Singhal S, Stadanlick J, Annunziata MJ, et al., 2019, Human
               19(6): 369–382.                                    tumor-associated monocytes/macrophages and their
                                                                  regulation of T cell responses in early-stage lung cancer. Sci
               https://doi.org/10.1038/s41577-019-0127-6
                                                                  Transl Med, 11(479): eaat1500.
            96.  Zhu Y, Herndon JM, Sojka DK, et al., 2017, Tissue-resident
               macrophages in pancreatic ductal adenocarcinoma originate      https://doi.org/10.1126/scitranslmed.aat1500
               from embryonic hematopoiesis and promote tumor   107. Laviron M, Boissonnas A, 2019, Ontogeny of tumor-
               progression. Immunity, 47(2): 323–338.e6.          associated macrophages. Front Immunol, 10: 1799.
               https://doi.org/10.1016/j.immuni.2017.07.014    108. Müller S, Kohanbash G, Liu SJ,  et al., 2017, Single-cell
                                                                  profiling of human gliomas reveals macrophage ontogeny as
            97.  Sica A, Bronte V, 2007, Altered macrophage differentiation   a basis for regional differences in macrophage activation in
               and  immune  dysfunction  in  tumor  development.  J  Clin   the tumor microenvironment. Genome Biol, 18: 234.
               Investig, 117(5): 1155–1166.
                                                               109. Bowman RL, Klemm F, Akkari L, et al., 2016, Macrophage
               https://doi.org/10.1172/JCI31422
                                                                  ontogeny underlies differences in tumor-specific education
            98.  Yin  M,  Li  X,  Tan  S,  et  al.,  2016,  Tumor-associated   in brain malignancies. Cell Rep, 17(9): 2445–2459.
               macrophages drive spheroid formation during early      https://doi.org/10.1016/j.celrep.2016.10.052
               transcoelomic metastasis of ovarian cancer. J Clin Investig,
               126(11): 4157–4173.                             110. Balkwill F, Mantovani A, 2001, Inflammation and cancer:
                                                                  Back to virchow? Lancet, 357(9255): 539–545.
               https://doi.org/10.1172/JCI87252
                                                                  https://doi.org/10.1016/S0140-6736(00)04046-0
            99.  Richards DM, Hettinger J, Feuerer M, 2013, Monocytes and
               macrophages in cancer: development and functions. Cancer   111. Kumar V, Patel S, Tcyganov E,  et al., 2016, The nature
               Microenviron, 6(2): 179–191.                       of Myeloid-Derived suppressor cells in the tumor
                                                                  microenvironment. Trends Immunol, 37(3): 208–220.
               https://doi.org/10.1007/s12307-012-0123-x
                                                                  https://doi.org/10.1016/j.it.2016.01.004
            100. Martinez FO, Helming L, Gordon S, 2009, Alternative
               activation of macrophages: An immunologic functional   112. Kumar V, Cheng P, Condamine T,  et al., 2016, CD45
               perspective. Annu Rev Immunol, 27: 451–483.        phosphatase inhibits STAT3 transcription factor activity in
                                                                  myeloid cells and promotes tumor-associated macrophage
               https://doi.org/10.1146/annurev.immunol.021908.132532  differentiation. Immunity, 44(2): 303–315.
            101. Mantovani A, Sozzani S, Locati M, et al., 2002, Macrophage      https://doi.org/10.1016/j.immuni.2016.01.014
               polarization: Tumor-associated macrophages as a paradigm
               for polarized M2 mononuclear phagocytes. Trends Immunol,   113. Laoui D,  Keirsse  J, Morias Y,  et al., 2016,  The tumour
               23(11): 549–555.                                   microenvironment harbours ontogenically distinct dendritic
                                                                  cell populations with opposing effects on tumour immunity.
               https://doi.org/10.1016/s1471-4906(02)02302-5      Nat Commun, 7: 13720.
            102. Minopoli M, Sarno S, Di Carluccio G, et al., 2020, Inhibiting      https://doi.org/10.1038/ncomms13720
               monocyte recruitment to prevent the pro-tumoral activity
               of tumor-associated macrophages in chondrosarcoma. Cells,   114. Veglia F, Gabrilovich DI, 2017, Dendritic cells in cancer: The
               9(4): 1062.                                        role revisited. Curr Opin Immunol, 45: 43–51.
                                                                  https://doi.org/10.1016/j.coi.2017.01.002
               https://doi.org/10.3390/cells9041062
                                                               115. Broz ML, Binnewies M, Boldajipour B, et al., 2014, Dissecting
            103. Murray PJ, Allen JE, Biswas SK, et al., 2014, Macrophage
               activation and polarization: nomenclature and experimental   the  tumor myeloid compartment  reveals  rare activating
               guidelines. Immunity, 41(1): 14–20.                antigen-presenting cells critical for T cell immunity. Cancer
                                                                  Cell, 26(5): 638–652.
               https://doi.org/10.1016/j.immuni.2014.06.008
                                                                  https://doi.org/10.1016/j.ccell.2014.09.007
            104. Azizi E, Carr AJ, Plitas G,  et al., 2018, Single-cell map
               of diverse immune phenotypes in the breast tumor   116. He YF, Wang CQ, Yu Y,  et al., 2015, Tie2-expressing
                                                                  monocytes are associated with identification and prognoses
               microenvironment. Cell, 174()5: 1293–1308.e36.
                                                                  of hepatitis B virus related hepatocellular carcinoma after
               https://doi.org/10.1016/j.cell.2018.05.060         resection. PLoS One, 10(11): e0143657.
            105. Vitale I, Shema E, Loi S,  et al., 2021, Intratumoral      https://doi.org/10.1371/journal.pone.0143657
               heterogeneity in cancer progression and response to   117. Awad  RM,  De  Vlaeminck  Y,  Maebe  J,  et al., 2018, Turn
               immunotherapy. Nat Med, 27(2): 212–224.
                                                                  back the TIMe: Targeting tumor infiltrating myeloid cells to
               https://doi.org/10.1038/s41591-021-01233-9         revert cancer progression. Front Immunol, 9: 1977.


            Volume 1 Issue 1 (2022)                         17                        https://doi.org/10.36922/td.v1i1.4
   21   22   23   24   25   26   27   28   29   30   31